You just read:

Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO

News provided by

Regeneron Pharmaceuticals, Inc.

May 16, 2018, 05:00 ET